ArticleJapanese journal of clinical oncology2021

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea.

Michinori Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.